Icahn Enterprises LP
NASDAQ:IEP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10.02
21.54
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Icahn Enterprises LP
Other Receivables
Icahn Enterprises LP
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Icahn Enterprises LP
NASDAQ:IEP
|
Other Receivables
$3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
||
R
|
Roper Technologies Inc
F:ROP
|
Other Receivables
$43m
|
CAGR 3-Years
17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
General Electric Co
NYSE:GE
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
3M Co
NYSE:MMM
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Honeywell International Inc
NASDAQ:HON
|
Other Receivables
$140m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
B
|
Brookfield Business Corp
TSX:BBUC
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Icahn Enterprises LP
Glance View
Icahn Enterprises LP is a diversified holding company founded by activist investor Carl Icahn, known for his aggressive approach to acquiring stakes in companies and pushing for governance changes. For over four decades, Icahn has built a reputation for identifying undervalued businesses with untapped potential. Icahn Enterprises operates across various industries, including energy, automotive, food packaging, metals, and real estate, making it a multifaceted portfolio that provides investors with exposure to different market sectors. The company’s investment philosophy revolves around the belief that intrinsic value can be unlocked through strategic changes, and Icahn's hands-on involvement often leads to significant operational improvements and increased shareholder value. Investors are attracted to Icahn Enterprises not only for its diverse holdings but also for its potential for high returns driven by Icahn's expertise in restructuring underperforming companies. As a publicly traded master limited partnership (MLP), it offers a unique investment structure that can provide tax benefits while offering a steady income stream through distributions. Icahn’s track record, characterized by bold moves and successful turnarounds, inspires confidence among investors, even as they navigate the inherent risks of activist investing. In a landscape where savvy investors seek opportunities for growth, Icahn Enterprises stands out as a compelling choice, combining a storied legacy of financial acumen with a robust, adaptable portfolio poised for future success.
See Also
What is Icahn Enterprises LP's Other Receivables?
Other Receivables
3B
USD
Based on the financial report for Sep 30, 2024, Icahn Enterprises LP's Other Receivables amounts to 3B USD.
What is Icahn Enterprises LP's Other Receivables growth rate?
Other Receivables CAGR 5Y
29%
Over the last year, the Other Receivables growth was -37%. The average annual Other Receivables growth rates for Icahn Enterprises LP have been -17% over the past three years , 29% over the past five years .